ACCESS was initially conceptualized, created, developed, and refined in an open clinical trial as part of the College STAR project (Supporting Transition Access Retention), funded by the Oak Foundation, GlaxoSmithKline, and a consortium of private foundations in Greensboro, NC. Under the direction of Drs. Arthur D. Anastopoulos (Principal Investigator) and Joshua M. Langberg (Co-Principal Investigator), our research team completed a comprehensive examination of the benefits of ACCESS in the context of a four-year, randomized controlled trial study, funded by the Institute of Education Sciences (IES) in the U.S. Department of Education. Findings from both trials lend strong support to its efficacy.